Page last updated: 2024-11-05

triamterene and Aqueductal Stenosis

triamterene has been researched along with Aqueductal Stenosis in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Research Excerpts

ExcerptRelevanceReference
"Hydrocephalus is a neurological condition caused by an abnormal accumulation of cerebrospinal fluid; pharmacological intervention of the disease has been found to elicit a variety of adverse drug reactions (ADRs) in central nervous system (CNS) by unexpectedly targeting certain functional neuroproteins."1.51Systematic analysis and identification of unexpected interactions from the neuroprotein drug interactome in hydrocephalus pharmacological intervention. ( Chen, X; Lu, Y; Yuan, L; Zhang, A; Zhang, P; Zou, D, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, Y1
Yuan, L1
Chen, X1
Zhang, A1
Zhang, P1
Zou, D1

Other Studies

1 other study available for triamterene and Aqueductal Stenosis

ArticleYear
Systematic analysis and identification of unexpected interactions from the neuroprotein drug interactome in hydrocephalus pharmacological intervention.
    Journal of bioinformatics and computational biology, 2019, Volume: 17, Issue:1

    Topics: Astrocytes; Cell Line; Computational Biology; Diuretics; Drug-Related Side Effects and Adverse React

2019